Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haoran Liu

Showing results (381-390 of 422) with videos related to

Pageof 43
Sort By:
Nanoscale|April 12, 2017
Multi-step encapsulation of chemotherapy and gene silencing agents in functionalized mesoporous silica nanoparticlesJianliang Shen, Haoran Liu, Chaofeng Mu, et al.
Urolithiasis|December 14, 2022
The influencing factors of infectious complications after percutaneous nephrolithotomy: a systematic review and meta-analysisGuiming Zhou, Yuan Zhou, Rui Chen, et al.
Frontiers in Oncology|October 9, 2023
Identification of alternative splicing associated with clinical features: from pan-cancers to genitourinary tumorsChen Duan, Yangjun Zhang, Lu Li, et al.
Theranostics|January 6, 2022
Erratum: Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: ErratumLibin Yan, Beichen Ding, Haoran Liu, et al.
Theranostics|January 6, 2022
Erratum: Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis: ErratumHaoran Liu, Xiaoqi Yang, Kun Tang, et al.
Theranostics|July 10, 2020
Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate NephrocalcinosisHaoran Liu, Xiaoqi Yang, Kun Tang, et al.
American Journal of Physiology. Renal Physiology|May 16, 2019
Pioglitazone decreased renal calcium oxalate crystal formation by suppressing M1 macrophage polarization via the PPAR-γ-miR-23 axisZhiqiang Chen, Peng Yuan, Xifeng Sun, et al.
Theranostics|November 18, 2020
AhR activation attenuates calcium oxalate nephrocalcinosis by diminishing M1 macrophage polarization and promoting M2 macrophage polarizationXiaoqi Yang, Haoran Liu, Tao Ye, et al.
Theranostics|November 23, 2019
Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinomaLibin Yan, Beichen Ding, Haoran Liu, et al.
Biomaterials|December 9, 2025
Injectable Calcium Phosphate Nanocomposite: Balancing Mechanical Support and Osseointegration for Enhanced Spinal Screw Fixation in an Osteoporosis Sheep ModelJianming Zhang, Haoran Liu, Chao Li, et al.
Pageof 43

Showing results (381-390 of 422) with videos related to

Sort By:
Pageof 43
Nanoscale|April 12, 2017
Multi-step encapsulation of chemotherapy and gene silencing agents in functionalized mesoporous silica nanoparticlesJianliang Shen, Haoran Liu, Chaofeng Mu, et al.
Urolithiasis|December 14, 2022
The influencing factors of infectious complications after percutaneous nephrolithotomy: a systematic review and meta-analysisGuiming Zhou, Yuan Zhou, Rui Chen, et al.
Frontiers in Oncology|October 9, 2023
Identification of alternative splicing associated with clinical features: from pan-cancers to genitourinary tumorsChen Duan, Yangjun Zhang, Lu Li, et al.
Theranostics|January 6, 2022
Erratum: Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: ErratumLibin Yan, Beichen Ding, Haoran Liu, et al.
Theranostics|January 6, 2022
Erratum: Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis: ErratumHaoran Liu, Xiaoqi Yang, Kun Tang, et al.
Theranostics|July 10, 2020
Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate NephrocalcinosisHaoran Liu, Xiaoqi Yang, Kun Tang, et al.
American Journal of Physiology. Renal Physiology|May 16, 2019
Pioglitazone decreased renal calcium oxalate crystal formation by suppressing M1 macrophage polarization via the PPAR-γ-miR-23 axisZhiqiang Chen, Peng Yuan, Xifeng Sun, et al.
Theranostics|November 18, 2020
AhR activation attenuates calcium oxalate nephrocalcinosis by diminishing M1 macrophage polarization and promoting M2 macrophage polarizationXiaoqi Yang, Haoran Liu, Tao Ye, et al.
Theranostics|November 23, 2019
Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinomaLibin Yan, Beichen Ding, Haoran Liu, et al.
Biomaterials|December 9, 2025
Injectable Calcium Phosphate Nanocomposite: Balancing Mechanical Support and Osseointegration for Enhanced Spinal Screw Fixation in an Osteoporosis Sheep ModelJianming Zhang, Haoran Liu, Chao Li, et al.
Pageof 43